Among them, Cumberland Pharmaceutical ( CPIX ), which focuses on commercializing branded prescription products, is down about 14% at $4.78 after it reported worse-than-expected results for Q2 late Tuesday. The company swung to a net loss of $0.6 million, or $0.03 per share, compared with a profit of $0.9 a year ago. And, WellCare Health Plans ( WCG ) is up near 10% at $66.40, having marked a 52-week high at $68.17, after it reported Q2 earnings of $1.35 per share, versus the Capital IQ consensus of $1.22.